Millennium Oncology India Private Limited (operating under trade name Medidect™ India) has partnered with Zyagnum AG, acquiring exclusive rights to deploy a breakthrough technology for tumors screening across India. We are legally registered under the name of MILLENNIUM ONCOLOGY INDIA PRIVATE LIMITED
PanTum® Detect is a simple, safe, non-invasive blood test with ground-breaking accuracy. The high specificity of 99%, combined with the high sensitivity of 97.5% is validated and unique to this day. With the successful IVD CE and Indian registration, Pantum® Detect is the first, and so far, the only multi tumor scanner for fast and inexpensive tumor screening by combining Imaging technology for confirmation and localization of tumors.
Medidect™ India will build and leverage existing capabilities and infrastructure of select players across the Indian healthcare ecosystem, typically Providers & Payors of medical cost. Early detection will trigger a much needed shift from complex late stage treatment to prevention and timely treatment with improved clinical outcomes at much lower costs.
About Us
Medidect™ India
Millennium Oncology India Private Limited (operating under trade name Medidect™ India) has partnered with Zyagnum AG, acquiring exclusive rights to deploy a breakthrough technology for early detection of all cancers across India.
PanTum Detect® is a simple, safe, non-invasive blood test with ground-breaking accuracy. The high specificity of 99%, combined with the high sensitivity of 97.5% is validated and unique to this day. With the successful IVD CE certification, Pantum Detect® is the first, and so far, the only universal (all cancer types) test for fast and inexpensive cancer screening.
Medidect™ India will build and levarage existing capabilities and infrastructure of select players across the Indian healthcare ecosystem, typically Providers & Payors of medical cost. Early detection will trigger a much needed shift from complex late stage treatment to prevention and timely treatment with improved clinical outcomes at much lower costs.
Our Vision
Towards a healthy & cancer free India.
Our Mission
Enable early-stage detection of tumors through affordable mass screening with PanTum® Detect.
Our Strategic Direction
Our team will lead the change to transform the healthcare eco-system towards mass annual multi-cancer screening for definitive early-stage diagnosis, timely treatment and protection against late-stage cancer.
Build infrastructure & testing capacity ahead of demand
Achieve mass scale access through mutually beneficial partnerships with Healthcare Providers & Payors of medical costs.
Enroll reputed Healthcare providers into an integrated and connected prevention, wellness and cancer care network
Leverage global know-how and multicountry network for global expansion.
OUR EXPERTSFounding Members
CO-FOUNDER & DIRECTOR
Dr. Gurdeep Singh Sethi, MD
Founder & Director, Millennium Cancer Center, India. Has over 30 years of experience in cancer management and immuno-oncology. He has spent over 26 years in the USA as a Senior Partner at an oncology chain. Practicing in India since 2015.
CO-FOUNDER & DIRECTOR
Gagandeep Singh Bedi
Healthcare professional with domain knowledge of Indian & International Healthcare eco-systems and business & financial acumen acquired from over three decades of experience from Leadership roles across Europe, Middle East & Africa, South America, South-East Asia and India.
CO-FOUNDER & DIRECTOR
Andreas Klein
Over 25 years in leadership roles in Europe, US, China and Asia and experience in international business management . He is also an advisor to the board of Zyagnum.
Leadership Team
Chief Operating Officer
Shiv Sagar Suri
Over 20 years in business development Advisory in Healthcare industry. Consulted with both Indian & International Companies for Market Expansion & Strategic Alliances. Was a Steering Committee Member of The Future Global Healthcare Hub (a PHD Chamber of Commerce & Industry Initiative).
Lab Director
Dr. Pramod Nath
Renowned Oncopathologist with 32 yrs of total experience in healthcare industry including 23 yrs in Armed Forces. Expertise in Histopathology & Cytology. Has been lab director & HOD in reputed hospitals.
Professional Advisors
Advisor
Rajiv Kapahi
Over 3 decades of experience in multi-industry domain as CXO & Board level engagements across MNC’s & Indian Business Houses in Healthcare, Insurance, IT / ITES, FMCG, Manufacturing & Office Automation sectors in India, APAC & EMEA.
Check eligibility for PanTum® Detect
blood test
Asymptomatic Healthy individuals with intact
immune system
Should not be undergoing cancer treatment or immunosuppressants drug
Should not be under influence of febrile illness, Inflammation, COVID, surgery or severe trauma in 8 weeks prior to blood sample draw
No vaccination in the last 4 weeks prior to blood sample draw.
For assistance from customer service executive, please fill form and submit